Dong-Wook Kang

This inventor holds 7 USPTO granted patents. Top assignees: Samjin Pharmaceutical Co., Ltd., Samjin Pharmaceuticazl Co., Ltd.. Active years: 1998-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-Wook Kang. Retrieved from https://idiyas.com/inventor/dong-wook-kang-7da20las

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7

% Patents Active = 71.4

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

JinJu, KR (1998)
Kwachon, KR (1999)
Kyungki-do, KR (2000 - 2007)

Company Filing History:

6 out of 13

Samjin Pharmaceutical Co., Ltd.

patents

1 out of 1

Samjin Pharmaceuticazl Co., Ltd.

patent

Years Active: 1998-2007

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7230105 - 9-aminoacridine derivatives and process for the preparation thereof (2007-06-12),

2. 6683184 - Piperazine derivatives and process for the preparation thereof (2004-01-27),

3. 6620936 - 9-aminoacridine derivatives and process for the preparation thereof (2003-09-16),

4. 6274732 - Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione (2001-08-14),

5. 6028195 - Piperazine derivatives and process for the preparation thereof (2000-02-22),

6. 5922727 - Antiviral substituted pyrimidinedione homocarbocyclic nucleoside (1999-07-13),

7. 5780472 - Piperazine derivatives and methods for the preparation thereof and (1998-07-14),

Title: The Innovative Contributions of Dong-Wook Kang

Introduction

Dong-Wook Kang is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of new chemical compounds. With a total of 7 patents to his name, Kang has demonstrated a commitment to advancing medical science.

Latest Patents

Among his latest patents, Kang has developed a new 9-aminoacridine derivative that exhibits prominent antitumor activity and low toxicity. This invention holds promise for cancer treatment, potentially offering a safer alternative to existing therapies. Additionally, he has worked on piperazine derivatives, further expanding the scope of his research in pharmaceutical applications.

Career Highlights

Kang has been associated with reputable companies such as Samjin Pharmaceutical Co., Ltd. and Samjin Pharmaceutical Co., Ltd. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of new medications.

Collaborations

Throughout his career, Kang has collaborated with esteemed colleagues, including Eui-Hwan Cho and Sun-Gan Chung. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Dong-Wook Kang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]